pros and cons of glp 1 for weight loss GLP-1 Agonists: Using Semaglutide, Tirzepatide, Orforglipron and Obesity Understanding GLP-1 Weight Loss Drugs

If approved, pills could lift capacity constraints and broaden adoption far beyond what cold-chain injectables alone can reach

Many employers that offer health plans that cover GLP-1 drugs impose conditions that plan participants must meet to qualify for such coverage

Podolsky MI, Raquib R, Shafer Pea et al (2025) Factors associated with semaglutide initiation among adults with obesity

Faced with a high-cost drug class hitting an optional budget line item, state Medicaid agencies were likely compelled to prioritize the immediate financial stability of the entire program

A new study from the Cleveland Clinic recently explored what happens when people stop taking GLP-1 medications